Nothing
##' Warfarin PK/PD data
##'
##' @format A data frame with 519 rows and 9 columns
##'
##' \describe{
##' \item{id}{Patient identifier (n=32)}
##' \item{time}{Time (h)}
##' \item{amt}{Total drug administered (mg)}
##' \item{dv}{Warfarin concentrations (mg/L) or PCA measurement}
##' \item{dvid}{Dependent identifier Information (cp: Dose or PK, pca: PCA, factor)}
##' \item{evid}{Event identifier}
##' \item{wt}{Weight (kg)}
##' \item{age}{Age (yr)}
##' \item{sex}{Sex (male or female, factor)}
##' }
##'
##' @source Funaki T, Holford N, Fujita S (2018). Population PKPD
##' analysis using nlmixr2 and NONMEM. PAGJA 2018
##'
##' @references
##'
##' O'Reilly RA, Aggeler PM, Leong LS. Studies of the coumarin
##' anticoagulant drugs: The pharmacodynamics of warfarin in man.
##' Journal of Clinical Investigation 1963; 42(10): 1542-1551
##'
##' O'Reilly RA, Aggeler PM. Studies on coumarin anticoagulant drugs
##' Initiation of warfarin therapy without a loading dose. Circulation
##' 1968; 38: 169-177.
##'
##' @family nlmixr2 datasets
"warfarin"
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.